Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma

Title
Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma
Authors
Keywords
-
Journal
Journal of Thoracic Oncology
Volume 7, Issue 9, Pages 1466-1470
Publisher
Elsevier BV
Online
2012-08-15
DOI
10.1097/jto.0b013e318260dfb9

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started